transcriptomics
Novigenix Raises $14M in First Closing of Series B
The Swiss company plans to use the funds for clinical validation of its NGS-based liquid biopsy, with a second Series B closing planned early next year.
HTG Molecular, OmiCure Partner to Use Transcriptome Panel to Guide Cancer Therapy
Samples from OmiCure will be sent to HTG's laboratory for testing with its transcriptome panel, and the data will be analyzed by OmiCure.
Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer
Premium
The firm envisions marketing the 53-gene signature with its existing MammaPrint and BluePrint tests as a comprehensive platform for breast cancer treatment selection.
The lead investigators have also spun out a company, Isabl, aiming to make the approach available to the broader community.
The company is assessing a variety of applications, including cancer early detection, using algorithms to analyze orphan noncoding RNA in blood.